Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II Melanoma
Clinical trial NCT04274816 · COMPLETED
Trial details
- NCT number
- NCT04274816
- Sponsor
- A.J.M. van den Eertwegh
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-10
- Primary completion
- 2014-02-27
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.